Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2011
05/17/2011US7943752 Modified oligonucleotides and applications thereof
05/17/2011US7943751 Ladder copolymers
05/17/2011US7943738 IL-17 receptor like molecules and uses thereof
05/17/2011US7943731 Dimerizing peptides
05/17/2011US7943592 RNAi inhibition of alpha-ENaC expression
05/17/2011US7943591 Gene expression and pain
05/17/2011US7943589 siRNA microbicides for preventing and treating diseases
05/17/2011US7943588 Method for preventing or treating neuropathic pain
05/17/2011US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
05/17/2011US7943366 Genetically modified yeast species and fermentation processes using genetically modified yeast
05/17/2011US7943364 Coryneform bacterium with reduced glutaminase and enhanced glutamine biosynthetic activity; animal feed and food processing
05/17/2011US7943362 Biosynthesis of phloroglucinol and preparation of 1,3-dihydroxybenzene therefrom
05/17/2011US7943361 Mutants of mycobacteria and process thereof
05/17/2011US7943360 Phospholipases, nucleic acids encoding them and methods for making and using them
05/17/2011US7943359 Polynucleotides which code for cyanide-tolerant nitrile hydratase and compositions thereof
05/17/2011US7943358 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying
05/17/2011US7943356 Alcohol dehydrogenase for the stereoselective production of hydroxy compounds
05/17/2011US7943346 Probes and primers for detection of bacterial pathogens and antibiotic resistance genes
05/17/2011US7943344 Hepatocyte growth factor (HGF) binding proteins
05/17/2011US7943341 Expression vector comprising nucleic acid which encodes signal sequence and heterologous protein; for use in transformation and expression in escherichia
05/17/2011US7943322 Polynucleotides for use as tags and tag complements, manufacture and use thereof
05/17/2011US7943321 Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
05/17/2011US7943320 Unsymmetrical cyanine dyes for high resolution nucleic acid melting analysis
05/17/2011US7943319 Utility of RET mutant in diagnosis and treatment of melanoma
05/17/2011US7943318 Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
05/17/2011US7943317 Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment
05/17/2011US7943316 Immunostimulatory oligonucleotides and uses thereof
05/17/2011US7943315 Methods for testing milk
05/17/2011US7943314 Methods of detecting viability-associated molecules
05/17/2011US7943313 Nucleotide sequences for classification and detection of prevotella denticola
05/17/2011US7943310 Methods for assessing response to therapy in subjects having ulcerative colitis
05/17/2011US7943307 Methods for analyzing nucleic acid sequences
05/17/2011US7943306 Gene expression signature for prediction of human cancer progression
05/17/2011US7943305 High speed nucleic acid sequencing
05/17/2011US7943304 Method and apparatus for chromosome profiling
05/17/2011US7943302 C20ORF23 as modifier of the IGFR pathway and methods of use
05/17/2011US7943301 DNA conformational switches as sensitive electronic sensors of analytes
05/17/2011US7943125 Attenuated gram negative bacteria
05/17/2011CA2382436C Methods for improving signal detection from an array
05/17/2011CA2320100C High affinity nucleic acid ligands of complement system proteins
05/17/2011CA2313957C Method for producing mass-coded combinatorial libraries
05/16/2011CA2723369A1 Association of the progesterone receptor with fertility
05/12/2011WO2011057171A1 METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM
05/12/2011WO2011057118A1 Anti-apoptotic agents and uses thereof
05/12/2011WO2011057027A2 Method for treating heart failure with stresscopin-like peptides
05/12/2011WO2011056883A1 Lipid formulated compositions and methods for inhibiting expression of transthyretin (ttr)
05/12/2011WO2011056721A2 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines
05/12/2011WO2011056644A2 Anti-glp-1r antibodies and their uses
05/12/2011WO2011056300A1 Methods and compositions for modulating tau levels
05/12/2011WO2011056186A1 Microrna affinity assay and uses thereof
05/12/2011WO2011056005A2 Novel sirna structure for minimizing off-target effects caused by antisense strands, and use thereof
05/12/2011WO2011055210A1 Hot spring bacterial strain bkh1 and protein isolated therefrom, concrete compositions, and uses thereof
05/12/2011WO2011054939A2 Compositions and methods for inhibiting expression of kif10 genes
05/12/2011WO2011054315A1 Use of cyr61 protein for preparing medicine
05/12/2011WO2011054150A1 Method of site-directed mutagenesis by overlapping pcr and use thereof in screening monoclonal antibody
05/12/2011WO2011017521A3 Bicyclic cyclohexose nucleic acid analogs
05/12/2011WO2010111674A3 Methods and apparatus for single molecule sequencing using energy transfer detection
05/12/2011WO2010108245A3 Use of leishmania antigens in a diagnostic method, vaccine and therapy for leishmaniasis
05/12/2011WO2010093860A4 Isolation of factors that associate directly or indirectly with chromatin
05/12/2011US20110113512 Trichome specific promoters
05/12/2011US20110113510 Promoters from Brassica Napus for Seed Specific Gene Expression
05/12/2011US20110113499 Altering Root Structure During Plant Development
05/12/2011US20110113498 Sirt1 polymorphic variants and methods of use thereof
05/12/2011US20110112284 Methods for modulating ikkalpha activity
05/12/2011US20110112283 Rna interference mediating small rna molecules
05/12/2011US20110112280 Use of rgm and its modulators
05/12/2011US20110112276 Mutated immunoglobulin-binding protein
05/12/2011US20110112186 Diagnostic methods
05/12/2011US20110112179 Cell line, system and method for optical control of secondary messengers
05/12/2011US20110112178 Compositions And Methods For Inhibiting Expression Of IKK-B Gene
05/12/2011US20110112177 Human G-Protein Coupled Receptor (HETGQ23)
05/12/2011US20110112176 Compositions and methods for inhibiting expression of kif10 genes
05/12/2011US20110112175 Peptide biosynthesis and pain therapy
05/12/2011US20110112172 SDF-1 Binding Nucleic Acids
05/12/2011US20110112170 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
05/12/2011US20110112169 RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA
05/12/2011US20110112168 Novel sirna structures
05/12/2011US20110112037 Crystal structure
05/12/2011US20110112022 Factor VIII Muteins with Reduced Immonugenicity
05/12/2011US20110112015 Use of glis3 for preparing functional pancreatic beta-cells
05/12/2011US20110112013 Novel Bacillus thuringiensis Gene with Lepidopteran Activity
05/12/2011US20110111983 siRNA targeting spleen tyrosine kinase
05/12/2011US20110111975 Probe for nucleic acid sequencing and methods of use
05/12/2011US20110111971 Methods for detection of genetic disorders
05/12/2011US20110111970 Microchip for identifying phellinus species and the method thereof
05/12/2011US20110111514 Labelling reagents having a pyridine nucleus bearing a diazomethyl function, process for synthesis of such reagents and processes for detection of biological molecules
05/12/2011US20110111501 Complex of polysaccharide and double-stranded rna
05/12/2011US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene
05/12/2011US20110111491 Rna interference suppresion of neurodegenerative diseases and methods of use thereof
05/12/2011US20110111479 Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs
05/12/2011US20110111477 Long acting formulation of biopharmaceutical
05/12/2011US20110111470 Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters
05/12/2011US20110111468 Variant lovd polypeptides and their uses
05/12/2011US20110111462 Composition and Method for Synthesizing a Deoxyribonucleotide Chain Using a Double Stranded Nucleic Acid Complex with a Thermostable Polymerase
05/12/2011US20110111457 Methods for microbial production of terpenoids
05/12/2011US20110111445 Peptide for Determining Actin Structures in Living Cells
05/12/2011US20110111423 Demethylated and / or oxidized membrane DNA
05/12/2011US20110111419 Copy Number Variations Predictive of Risk of Schizophrenia
05/12/2011US20110111417 Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
05/12/2011US20110111411 Protein-Responsive RNA Control Devices and Uses Thereof